Department of Health Policy Archives
Jul. 15, 2019—The nation’s opioid crisis is a factor in the recent increase in the number of infants entering the nation’s foster care system, with at least half of all infant placements now a result of parental substance use.
Jul. 1, 2019—Medicare Part D enrollees may pay more out of pocket for high-priced specialty generic drugs than their brand-name counterparts, according to new research by health policy experts at Vanderbilt University Medical Center and the University of North Carolina at Chapel Hill.
Jun. 20, 2019—Vanderbilt University Medical Center is forming a new Center for Improving the Public’s Health Using Informatics (CIPHI, pronounced “Sci Fi”) to be co-directed by Michael Matheny, MD, MS, MPH, and Melissa McPheeters, PhD, MPH.
Apr. 4, 2019—Tobacco control legislative initiatives in Tennessee and other states were discussed during the spring Research into Policy and Practice Lecture sponsored by the Department of Health Policy at Vanderbilt University Medical Center and NashvilleHealth.
Feb. 14, 2019—Stephen Patrick, MD, MPH, MS, has been named to receive the Society for Pediatric Research 2019 Young Investigator Award, an honor bestowed upon a young physician who has embarked on a career in investigative pediatrics.
Dec. 13, 2018—Experts from Vanderbilt University School of Medicine’s Department of Health Policy and Vanderbilt University’s Peabody College of Education and Human Development are joining efforts to establish a Policies for Action (P4A) Research Hub at Vanderbilt to better understand and develop recommendations to address the needs of some of Tennessee’s most vulnerable children, including those in immigrant families and with prenatal exposure to opioids.
Dec. 12, 2018—Children and young adults without psychosis who are prescribed high-dose antipsychotic medications are at increased risk of unexpected death, despite the availability of other medications to treat their conditions, according to a Vanderbilt University Medical Center study published today in JAMA Psychiatry. Unexpected death includes deaths due to unintentional drug overdose or cardiovascular/metabolic causes.
Dec. 6, 2018—William Schaffner, MD, professor of Preventive Medicine in the Department of Health Policy and professor of Medicine in the Division of Infectious Diseases, is the recipient of the 2018 D.A. Henderson Award for Outstanding Contributions to Public Health.
Study defines association of oral anticoagulants and proton pump inhibitors to gastrointestinal bleeding risk
Dec. 4, 2018—A Vanderbilt University Medical Center study published this week in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.
Nov. 29, 2018—Precision medicine research — which involves the consolidation of massive amounts of complex data and the widespread sharing of those data for a variety of research studies — offers the prospect of both benefit and harm.
Nov. 20, 2018—The Incoming class of elected officials will encounter a variety of outstanding — yet often overlooked — health care policy questions that will impact health and providers across Tennessee.
Sep. 27, 2018—Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.